Monitoring Patients with Parkinson’s Disease Using Gamma-glutamyl cysteine Supplementation
Have you recently been diagnosed with Parkinson’s Disease? You may be eligible for a research study investigating how the antioxidant, gamma-glutamylcysteine (GGC), affects brain health, motor function, oxidative stress and cognitive function. Participation includes MRI scans, cognitive testing, and blood and stool analysis to assess changes over time. Compensation is provided.